NeoGenomics Inc. (NEO)
NASDAQ: NEO
· Real-Time Price · USD
7.17
-0.11 (-1.51%)
At close: Jun 02, 2025, 3:59 PM
7.24
0.94%
After-hours: Jun 02, 2025, 07:54 PM EDT
NeoGenomics Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Commercial Insurance Revenue | 99.84M |
| Commercial Insurance Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 90.89M | 85.98M | 87.38M | 81.55M | 82.57M | 77.83M | 79.1M | 79.21M | 77.81M | 75M | 81.09M | 75.02M | 82.55M | 78.31M | 79.54M | 71.86M | 54.23M | 49.81M | 47.43M | 44.81M | 49.6M | 45.52M | 44.56M | 41.9M | 43.36M | 33.76M | 27.95M | 28.66M | 23.84M | 28.09M | 29.84M | 28.92M | 26.45M | 25.8M | 24.98M | 25.11M | 23.8M | 15.59M | 10.19M | 9.98M | 9.44M |
| Selling, General, and Administrative Revenue Growth | +5.71% | -1.60% | +7.15% | -1.23% | +6.09% | -1.60% | -0.14% | +1.80% | +3.75% | -7.52% | +8.09% | -9.12% | +5.41% | -1.55% | +10.69% | +32.53% | +8.85% | +5.02% | +5.86% | -9.66% | +8.96% | +2.15% | +6.35% | -3.36% | +28.41% | +20.78% | -2.47% | +20.22% | -15.12% | -5.88% | +3.21% | +9.33% | +2.52% | +3.27% | -0.49% | +5.47% | +52.72% | +53.02% | +2.04% | +5.79% | n/a |
| Research and Development Revenue | 10.18M | 7.97M | 7.68M | 7.89M | 7.62M | 7.13M | 5.29M | 7.5M | 7.39M | 6.67M | 7.31M | 8.63M | 7.71M | 8.51M | 7.41M | 3.5M | 2.46M | 2.1M | 1.96M | 2.1M | 2.06M | 2.08M | 2.61M | 2.59M | 1.21M | 526K | 446K | 1.07M | 956K | 556K | 1.27M | 947K | 862K | 930K | 967K | 1.31M | 1.45M | 1.86M | 871K | 803K | 669K |
| Research and Development Revenue Growth | +27.76% | +3.71% | -2.56% | +3.49% | +6.92% | +34.85% | -29.55% | +1.45% | +10.79% | -8.71% | -15.23% | +11.84% | -9.40% | +14.90% | +111.99% | +42.30% | +16.95% | +6.92% | -6.70% | +2.18% | -0.96% | -20.34% | +0.93% | +113.98% | +129.85% | +17.94% | -58.43% | +12.24% | +71.94% | -56.22% | +34.11% | +9.86% | -7.31% | -3.83% | -25.96% | -9.68% | -22.09% | +113.09% | +8.47% | +20.03% | n/a |
| Sales and Marketing Revenue | 22.68M | 22.34M | 20.41M | 21.68M | 20.22M | 18.07M | 17.61M | 18.9M | 16.26M | 17.14M | 16.81M | 17.07M | 16.3M | 15.92M | 15.7M | 17.22M | 13.75M | 13.11M | 11.3M | 10.2M | 13.26M | 12.3M | 11.51M | 12.32M | 11.22M | 8.05M | 6.9M | 7.68M | 6.78M | 6.08M | 6.58M | 6.24M | 5.65M | 5.83M | 5.96M | 6.33M | 5.8M | 2.99M | 2.75M | 2.91M | 2.91M |
| Sales and Marketing Revenue Growth | +1.54% | +9.42% | -5.82% | +7.20% | +11.89% | +2.62% | -6.83% | +16.25% | -5.15% | +1.98% | -1.53% | +4.74% | +2.40% | +1.36% | -8.82% | +25.27% | +4.91% | +15.93% | +10.88% | -23.10% | +7.77% | +6.90% | -6.62% | +9.88% | +39.38% | +16.62% | -10.16% | +13.36% | +11.49% | -7.60% | +5.37% | +10.52% | -3.04% | -2.23% | -5.83% | +9.09% | +93.79% | +8.92% | -5.47% | -0.24% | n/a |